NOVOCAIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Novocain, and when can generic versions of Novocain launch?
Novocain is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in NOVOCAIN is procaine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the procaine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NOVOCAIN?
- What are the global sales for NOVOCAIN?
- What is Average Wholesale Price for NOVOCAIN?
Summary for NOVOCAIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 86 |
| Patent Applications: | 4,870 |
| DailyMed Link: | NOVOCAIN at DailyMed |
US Patents and Regulatory Information for NOVOCAIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 085362-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 085362-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | NOVOCAIN | procaine hydrochloride | INJECTABLE;INJECTION | 086797-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
